Article Details

Versanis Bio unveils $70M and a Novartis drug ready for Phase 2 test in obesity - MedCity News

Retrieved on: 2021-08-31 18:45:00

Tags for this article:

Click the tags to see associated articles and topics

Versanis Bio unveils $70M and a Novartis drug ready for Phase 2 test in obesity - MedCity News. View article details on hiswai:

Excerpt

The Series A financing announced Tuesday was led by Atlas Venture and Medicxi. Aditum Bio, the investment firm that founded Versanis, also invested in the ...

Article found on: medcitynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up